Myomo (MYO) Enterprise Value (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46.52% |
| Sep 30, 2025 | 20.83% |
| Jun 30, 2025 | 35.20% |
| Mar 31, 2025 | 3.06% |
| Dec 31, 2024 | -260.70% |
| Sep 30, 2024 | 22.09% |
| Jun 30, 2024 | 18.04% |
| Mar 31, 2024 | -23.60% |
| Dec 31, 2023 | 20.27% |
| Sep 30, 2023 | 6.61% |
| Jun 30, 2023 | -28.53% |
| Mar 31, 2023 | -73.28% |
| Dec 31, 2022 | 27.76% |
| Sep 30, 2022 | 27.71% |
| Jun 30, 2022 | 20.91% |
| Mar 31, 2022 | 16.63% |
| Dec 31, 2021 | -23.14% |
| Sep 30, 2021 | 8.46% |
| Jun 30, 2021 | 20.72% |
| Mar 31, 2021 | -41.91% |
| Dec 31, 2020 | 8.08% |
| Sep 30, 2020 | -24.08% |
| Jun 30, 2020 | 21.81% |
| Mar 31, 2020 | -207.39% |
| Dec 31, 2019 | -3.17% |
| Sep 30, 2019 | 35.10% |
| Jun 30, 2019 | 27.78% |
| Mar 31, 2019 | -41.17% |
| Dec 31, 2018 | 28.07% |
| Sep 30, 2018 | 22.17% |
| Jun 30, 2018 | 17.23% |
| Mar 31, 2018 | -8.93% |
| Dec 31, 2017 | -161.38% |
| Sep 30, 2017 | 30.27% |
| Jun 30, 2017 | -791.93% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | -61.63% |
| Sep 30, 2016 | 23.43% |